Randomized trial shows TH-001 improved HbA1c and reduced body weight in adults with prediabetes, indicating digital solutions may enhance diabetes prevention efforts.
Key Points
TH-001 significantly reduced HbA1c levels by 0.22%, suggesting its potential effectiveness in managing prediabetes.
In addition to HbA1c, body weight was reduced by 2.53 kg, highlighting the intervention's impact on overall health metrics.
A total of 68 adults participated in a randomized trial comparing TH-001 with standard care, strengthening the findings' reliability.
High user engagement was associated with HbA1c reduction, pointing to the importance of digital therapeutic interaction in diabetes management.